Utah Medical Products, Inc. (UTMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Utah Medical Products, Inc. (UTMD) is up 20.0% since the beginning of the year. At $67 per share, UTMD is trading 6.9% below its 52-week high of $72. Investors who bought $1,000 worth of UTMD shares 5 years ago would now be looking at an investment worth $886.

Utah Medical Products, Inc. (UTMD) has returned 19.99% so far this year and 24.64% over the past 12 months. Over the last ten years, UTMD has returned 1.87% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Mar 8, 1999, UTMD's average daily return is +0.06%, while the average monthly return is +1.15%. At this rate, an investment would double in approximately 5.1 years.

Historically, 54% of months were positive and 46% were negative. The best month was Jan 2001 with a return of +26.7%, while the worst month was Aug 2004 at -30.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, UTMD closed higher 47% of trading days. The best single day was Dec 14, 2000 with a return of +26.4%, while the worst single day was Aug 10, 2004 at -32.8%.

Utah Medical Products, Inc. has an annualized alpha of 13.56%, beta of 0.34, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since March 09, 1999.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (50.75%) than losses (17.36%) - typical of diversified or defensive assets.
• Beta of 0.34 may look defensive, but with R2 of 0.05 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

UTMD ranks 68 for risk / return — better than 68% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and compare them to S&P 500 Index.

Utah Medical Products, Inc. provided a 1.84% dividend yield over the last twelve months, with an annual payout of $1.23 per share. The company has been increasing its dividends for 3 consecutive years.

The table displays the monthly dividend distributions for Utah Medical Products, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Utah Medical Products, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Utah Medical Products, Inc. was 55.58%, occurring on Apr 30, 2025. The portfolio has not yet recovered.

The current Utah Medical Products, Inc. drawdown is 41.45%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Utah Medical Products, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Utah Medical Products, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.